TherapeuticsMD Inc.
TXMD | NASDAQ
$2.14
+$0.04 (+1.90%)
Sep 22, 2026, 12:46 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Net Income | -653K | -2.31M | -7.7M | 1.07M | -79.31M | -183.52M |
Depreciation & Amortization | 1.19M | 509K | 922K | 1.19M | 736K | 4.07M |
Stock-Based Compensation | n/a | n/a | n/a | 11.57M | n/a | 10.68M |
Other Working Capital | 1.54M | 1.43M | -15.31M | -2.88M | 10.69M | 6.33M |
Other Non-Cash Items | 221K | 875K | -23.92M | -13.83M | -73.83M | 12.65M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.66M | 1.66M | -17.45M | -4.09M | 4.59M | -3.34M |
Operating Cash Flow | 2.42M | 732K | -48.14M | -4.08M | -147.81M | -159.47M |
Capital Expenditures | n/a | n/a | 48.14M | -355K | -34K | -1.6M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 223.83M | n/a | -1.39M |
Investing Cash Flow | n/a | n/a | n/a | 223.48M | -2.22M | -1.6M |
Debt Repayment | n/a | n/a | n/a | -219.43M | -50M | 50M |
Common Stock Repurchased | n/a | n/a | n/a | -38.66M | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | -1.27M | n/a | -978K |
Financial Cash Flow | n/a | n/a | 3.15M | -235.21M | 134.67M | 80.73M |
Net Cash Flow | 2.42M | 732K | -44.99M | -15.81M | -15.58M | -80.34M |
Free Cash Flow | 2.42M | 732K | n/a | -4.43M | -147.85M | -161.07M |
Adj. Free Cash Flow | 2.42M | 732K | n/a | -16.01M | -147.85M | -171.75M |
Maintenance CapEx | n/a | n/a | 48.14M | n/a | -34K | n/a |
Growth CapEx | n/a | n/a | n/a | -355K | n/a | -1.6M |
Owner Earnings | 2.42M | 732K | n/a | -4.08M | -147.85M | -159.47M |
Add to Watchlist
Select watchlists to add or remove TXMD